Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)
Hong Kong · Delayed Price · Currency is HKD 18.76
+0.19 (1.02%)
Oct 31, 2025, 4:08 PM HKT
HKG:0874 Market Cap
HKG:0874 has a market cap or net worth of 44.6 billion as of October 31, 2025. Its market cap has decreased by -14.68% in one year.
Market Cap
44.60B
Enterprise Value
44.43B
Revenue
84.74B
Ranking
n/a
PE Ratio
13.66
Stock Price
18.76
Market Cap Chart
Since February 6, 2001, HKG:0874's market cap has increased from 3.51B to 44.60B, an increase of 1,169.53%. That is a compound annual growth rate of 10.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 44.62B | -4.08% |
| Dec 31, 2024 | 46.52B | -5.21% |
| Dec 29, 2023 | 49.08B | -6.35% |
| Dec 30, 2022 | 52.40B | -18.06% |
| Dec 31, 2021 | 63.96B | 20.63% |
| Dec 31, 2020 | 53.02B | -14.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 263.63B |
| Hansoh Pharmaceutical Group Company | 207.05B |
| JD Health International | 194.33B |
| WuXi Biologics | 148.69B |
| Innovent Biologics | 138.28B |
| Sino Biopharmaceutical | 122.81B |
| Akeso | 102.15B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.31B |